Biotech Stocks: Why Expensive U.S. Drug Trials Are Pushing Pharma Research Overseas

Palm Beach, FL –May 7, 2019 – American pharmaceutical and biotech companies who need to conduct clinical trials are looking more and more to conduct them overseas in the European Union, because the EU offers lower cost alternatives to U.S. trials… which not only saves money, buy also can save time to market. Many U.S. […]

Guardion’s Lumega-Z Formula Associated with Improved Vision in Patients with Severe Glaucoma

In a recent study presented at the Association for Research in Vision and Ophthalmology (ARVO) 2019 annual meeting, treatment with Lumega-Z was associated with significant improvement in Visual Field function among patients with severe glaucoma   San Diego, CA – May 7, 2019 – Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), an […]

Moleculin Announces Additional Positive Interim Results in First Cohort of Phase 1/2 Clinical Studies of Annamycin in Acute Myeloid Leukemia in Europe

2 of 3 patients qualify to proceed to a potentially curative bone marrow transplant; trial advances to next higher dose level   Houston, TX – May 7, 2019 – Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors, today […]

Mainstream CBD Acceptance Being Driven By Boomers and Millennials

FN Media Group Presents Potstocknews.com Market Commentary   New York, NY – May 7, 2019 – Sales of cannabidiol (CBD) oil are dramatically rising across North America, as its availability on mainstream shelves caters to growing health, wellness, and beauty markets. Much of this growth is being driven at two ends of the age spectrum, […]